The authors hypothesized that in AD, an initial step in the pathogenesis may be the intracellular binding of soluble Aβ to soluble non-phosphorylated tau, thus promoting tau phosphorylation and Aβ nucleation [157]. The gene discussed is MAPT; the disease is Alzheimer disease.